NT
-
KAIST Enables On-Site Disease Diagnosis in Just 3 Minutes... Nanozyme Reaction Selectivity Improved 38-Fold
<(From Left) Professor Jinwoo Lee, Ph.D candidate Seonhye Park and Ph.D candidate Daeeun Choi from Chemical & Biomolecular Engineering>
To enable early diagnosis of acute illnesses and effective management of chronic conditions, point-of-care testing (POCT) technology—diagnostics conducted near the patient—is drawing global attention. The key to POCT lies in enzymes that recognize and react precisely with specific substances. However, traditional natural enzymes are expensive and unstable, and nanozymes (enzyme-mimicking catalysts) have suffered from low reaction selectivity. Now, a Korean research team has developed a high-sensitivity sensor platform that achieves 38 times higher selectivity than existing nanozymes and allows disease diagnostics visible to the naked eye within just 3 minutes.
On the 28th, KAIST (President Kwang Hyung Lee) announced that Professor Jinwoo Lee’s research team from the Department of Chemical & Biomolecular Engineering, in collaboration with teams led by Professor Jeong Woo Han at Seoul National University and Professor Moon Il Kim at Gachon University, has developed a new single-atom catalyst that selectively performs only peroxidase-like reactions while maintaining high reaction efficiency.
Using bodily fluids such as blood, urine, or saliva, this diagnostic platform enables test results to be read within minutes even outside hospital settings—greatly improving medical accessibility and ensuring timely treatment. The key lies in the visual detection of biomarkers (disease indicators) through color changes triggered by enzyme reactions. However, natural enzymes are expensive and easily degraded in diagnostic environments, limiting their storage and distribution.
To address this, inorganic nanozyme materials have been developed as substitutes. Yet, they typically lack selectivity—when hydrogen peroxide is used as a substrate, the same catalyst triggers both peroxidase-like reactions (which cause color change) and catalase-like reactions (which remove the substrate), reducing diagnostic signal accuracy.
To control catalyst selectivity at the atomic level, the researchers used an innovative structural design: attaching chlorine (Cl) ligands in a three-dimensional configuration to the central ruthenium (Ru) atom to fine-tune its chemical properties. This enabled them to isolate only the desired diagnostic signal.
<Figure1. The catalyst in this study (ruthenium single-atom catalyst) exhibits peroxidase-like activity with selectivity akin to natural enzymes through three-dimensional directional ligand coordination. Due to the absence of competing catalase activity, selective peroxidase-like reactions proceed under biomimetic conditions. In contrast, conventional single-atom catalysts with active sites arranged on planar surfaces exhibit dual functionality depending on pH. Under neutral conditions, their catalase activity leads to hydrogen peroxide depletion, hindering accurate detection. The catalyst in this study eliminates such interference, enabling direct detection of biomarkers through coupled reactions with oxidases without the need for cumbersome steps like buffer replacement. The ability to simultaneously detect multiple target substances under biomimetic conditions demonstrates the practicality of ruthenium single-atom catalysts for on-site diagnostics>
Experimental results showed that the new catalyst achieved over 38-fold improvement in selectivity compared to existing nanozymes, with significantly increased sensitivity and speed in detecting hydrogen peroxide. Even in near-physiological conditions (pH 6.0), the catalyst maintained its performance, proving its applicability in real-world diagnostics.
By incorporating the catalyst and oxidase into a paper-based sensor, the team created a system that could simultaneously detect four key biomarkers related to health: glucose, lactate, cholesterol, and choline—all with a simple color change.
This platform is broadly applicable across various disease diagnostics and can deliver results within 3 minutes without complex instruments or pH adjustments. The findings show that diagnostic performance can be dramatically improved without changing the platform itself, but rather by engineering the catalyst structure.
<Figure 2.(a) Schematic diagram of the paper sensor (Zone 1: glucose oxidase immobilized; Zone 2: lactate oxidase immobilized; Zone 3: choline oxidase immobilized; Zone 4: cholesterol oxidase immobilized; Zone 5: no oxidase enzyme). (b) Single biomarker (single disease indicator) detection using the ruthenium single‑atom catalyst–based paper sensor.(c) Multiple biomarker (multiple disease indicator) detection using the ruthenium single‑atom catalyst–based paper sensor>
Professor Jinwoo Lee of KAIST commented, “This study is significant in that it simultaneously achieves enzyme-level selectivity and reactivity by structurally designing single-atom catalysts.” He added that “the structure–function-based catalyst design strategy can be extended to the development of various metal-based catalysts and other reaction domains where selectivity is critical.”
Seonhye Park and Daeeun Choi, both Ph.D. candidates at KAIST, are co-first authors. The research was published on July 6, 2025, in the prestigious journal Advanced Materials
-Title: Breaking the Selectivity Barrier of Single-Atom Nanozymes Through Out-of-Plane Ligand Coordinatio
- Authors: Seonhye Park (KAIST, co–first author), Daeeun Choi (KAIST, co–first author), Kyu In Shim (SNU, co–first author), Phuong Thy Nguyen (Gachon Univ., co–first author), Seongbeen Kim (KAIST), Seung Yeop Yi (KAIST), Moon Il Kim (Gachon Univ., corresponding author), Jeong Woo Han (SNU, corresponding author), Jinwoo Lee (KAIST, corresponding author
-DOI: https://doi.org/10.1002/adma.202506480
This research was supported by the Ministry of Science and ICT and the National Research Foundation of Korea (NRF).
2025.07.29 View 470 -
Immune Signals Directly Modulate Brain's Emotional Circuits: Unraveling the Mechanism Behind Anxiety-Inducing Behaviors
KAIST's Department of Brain and Cognitive Sciences, led by Professor Jeong-Tae Kwon, has collaborated with MIT and Harvard Medical School to make a groundbreaking discovery. For the first time globally, their joint research has revealed that cytokines, released during immune responses, directly influence the brain's emotional circuits to regulate anxiety behavior.
The study provided experimental evidence for a bidirectional regulatory mechanism: inflammatory cytokines IL-17A and IL-17C act on specific neurons in the amygdala, a region known for emotional regulation, increasing their excitability and consequently inducing anxiety. Conversely, the anti-inflammatory cytokine IL-10 was found to suppress excitability in these very same neurons, thereby contributing to anxiety alleviation.
In a mouse model, the research team observed that while skin inflammation was mitigated by immunotherapy (IL-17RA antibody), anxiety levels paradoxically rose. This was attributed to elevated circulating IL-17 family cytokines leading to the overactivation of amygdala neurons.
Key finding: Inflammatory cytokines IL-17A/17C promote anxiety by acting on excitable amygdala neurons (via IL-17RA/RE receptors), whereas anti-inflammatory cytokine IL-10 alleviates anxiety by suppressing excitability through IL-10RA receptors on the same neurons.
The researchers further elucidated that the anti-inflammatory cytokine IL-10 works to reduce the excitability of these amygdala neurons, thereby mitigating anxiety responses.
This research marks the first instance of demonstrating that immune responses, such as infections or inflammation, directly impact emotional regulation at the level of brain circuits, extending beyond simple physical reactions. This is a profoundly significant achievement, as it proposes a crucial biological mechanism that interlinks immunity, emotion, and behavior through identical neurons within the brain.
The findings of this research were published in the esteemed international journal Cell on April 17th of this year.
Paper Information:
Title: Inflammatory and anti-inflammatory cytokines bidirectionally modulate amygdala circuits regulating anxiety
Journal: Cell (Vol. 188, 2190–2220), April 17, 2025
DOI: https://doi.org/10.1016/j.cell.2025.03.005
Corresponding Authors: Professor Gloria Choi (MIT), Professor Jun R. Huh (Harvard Medical School)
2025.07.24 View 497 -
Approaches to Human-Robot Interaction Using Biosignals
<(From left) Dr. Hwa-young Jeong, Professor Kyung-seo Park, Dr. Yoon-tae Jeong, Dr. Ji-hoon Seo, Professor Min-kyu Je, Professor Jung Kim >
A joint research team led by Professor Jung Kim of KAIST Department of Mechanical Engineering and Professor Min-kyu Je of the Department of Electrical and Electronic Engineering recently published a review paper on the latest trends and advancements in intuitive Human-Robot Interaction (HRI) using bio-potential and bio-impedance in the internationally renowned academic journal 'Nature Reviews Electrical Engineering'.
This review paper is the result of a collaborative effort by Dr. Kyung-seo Park (DGIST, co-first author), Dr. Hwa-young Jeong (EPFL, co-first author), Dr. Yoon-tae Jeong (IMEC), and Dr. Ji-hoon Seo (UCSD), all doctoral graduates from the two laboratories. Nature Reviews Electrical Engineering is a review specialized journal in the field of electrical, electronic, and artificial intelligence technology, newly launched by Nature Publishing Group last year. It is known to invite world-renowned scholars in the field through strict selection criteria. Professor Jung Kim's research team's paper, titled "Using bio-potential and bio-impedance for intuitive human-robot interaction," was published on July 18, 2025. (DOI: https://doi.org/10.1038/s44287-025-00191-5)
This review paper explains how biosignals can be used to quickly and accurately detect movement intentions and introduces advancements in movement prediction technology based on neural signals and muscle activity. It also focuses on the crucial role of integrated circuits (ICs) in maximizing low-noise performance and energy efficiency in biosignal sensing, covering thelatest development trends in low-noise, low-power designs for accurately measuring bio-potential and impedance signals.
The review emphasizes the importance of hybrid and multi-modal sensing approaches, presenting the possibility of building robust, intuitive, and scalable HRI systems. The research team stressed that collaboration between sensor and IC design fields is essential for the practical application of biosignal-based HRI systems and stated that interdisciplinary collaboration will play a significant role in the development of next-generation HRI technology. Dr. Hwa-young Jeong, a co-first author of the paper, presented the potential of bio-potential and impedance signals to make human-robot interaction more intuitive and efficient, predicting that it will make significant contributions to the development of HRI technologies such as rehabilitation robots and robotic prostheses using biosignals in the future. This research was supported by several research projects, including the Human Plus Project of the National Research Foundation of Korea.
2025.07.24 View 555 -
KAIST Team Develops Optogenetic Platform for Spatiotemporal Control of Protein and mRNA Storage and Release
<Dr. Chaeyeon Lee, Professor Won Do Heo from Department of Biological Sciences>
A KAIST research team led by Professor Won Do Heo (Department of Biological Sciences) has developed an optogenetic platform, RELISR (REversible LIght-induced Store and Release), that enables precise spatiotemporal control over the storage and release of proteins and mRNAs in living cells and animals.
Traditional optogenetic condensate systems have been limited by their reliance on non-specific multivalent interactions, which can lead to unintended sequestration or release of endogenous molecules. RELISR overcomes these limitations by employing highly specific protein–protein (nanobody–antigen) and protein–RNA (MCP–MS2) interactions, enabling the selective and reversible compartmentalization of target proteins or mRNAs within engineered, membrane-less condensates.
In the dark, RELISR stably sequesters target molecules within condensates, physically isolating them from the cellular environment. Upon blue light stimulation, the condensates rapidly dissolve, releasing the stored proteins or mRNAs, which immediately regain their cellular functions or translational competency. This allows for reversible and rapid modulation of molecular activities in response to optical cues.
< Figure 1. Overview of the Artificial Condensate System (RELISR). The artificial condensate system, RELISR, includes "Protein-RELISR" for storing proteins and "mRNA-RELISR" for storing mRNA. These artificial condensates can be disassembled by blue light irradiation and reassembled in a dark state>
The research team demonstrated that RELISR enables temporal and spatial regulation of protein activity and mRNA translation in various cell types, including cultured neurons and mouse liver tissue. Comparative studies showed that RELISR provides more robust and reversible control of translation than previous systems based on spatial translocation.
While previous optogenetic systems such as LARIAT (Lee et al., Nature Methods, 2014) and mRNA-LARIAT (Kim et al., Nat. Cell Biol., 2019) enabled the selective sequestration of proteins or mRNAs into membrane-less condensates in response to light, they were primarily limited to the trapping phase. The RELISR platform introduced in this study establishes a new paradigm by enabling both the targeted storage of proteins and mRNAs and their rapid, light-triggered release. This approach allows researchers to not only confine molecular function on demand, but also to restore activity with precise temporal control.
< Figure 2. Cell shape change using the artificial condensate system (RELISR). A target protein, Vav2, which contributes to cell shape, was stored within the artificial condensate and then released after light irradiation. This release activated the target protein Vav2, causing a change in cell shape. It was confirmed that the storage, release, and activation of various proteins were effectively achieved>
Professor Heo stated, “RELISR is a versatile optogenetic tool that enables the precise control of protein and mRNA function at defined times and locations in living systems. We anticipate this platform will be broadly applicable for studies of cell signaling, neural circuits, and therapeutic development. Furthermore, the combination of RELISR with genome editing or tissue-targeted delivery could further expand its utility for molecular medicine.”
< Figure 3. Expression of a target mRNA using the artificial condensate system (RELISR) in mice. The genetic material for the artificial condensate system, RELISR, was injected into a living mouse. Using this system, a target mRNA was stored within the mouse's liver. Upon light irradiation, the mRNA was released, which induced the translation of a luminescent protein>
This research was conducted by first author Dr. Chaeyeon Lee, under the supervision of Professor Heo, with contributions from Dr. Daseuli Yu (co-corresponding author) and Professor YongKeun Park (co-corresponding author, Department of Physics), whose group performed quantitative imaging analyses of biophysical changes induced by RELISR in cells.
The findings were published in Nature Communications (July 7, 2025; DOI: 10.1038/s41467-025-61322-y). This work was supported by the Samsung Future Technology Foundation and the National Research Foundation of Korea.
2025.07.23 View 375 -
Why Do Plants Attack Themselves? The Secret of Genetic Conflict Revealed
<Professor Ji-Joon Song of the KAIST Department of Biological Sciences>
Plants, with their unique immune systems, sometimes launch 'autoimmune responses' by mistakenly identifying their own protein structures as pathogens. In particular, 'hybrid necrosis,' a phenomenon where descendant plants fail to grow healthily and perish after cross-breeding different varieties, has long been a difficult challenge for botanists and agricultural researchers. In response, an international research team has successfully elucidated the mechanism inducing plant autoimmune responses and proposed a novel strategy for cultivar improvement that can predict and avoid these reactions.
Professor Ji-Joon Song's research team at KAIST, in collaboration with teams from the National University of Singapore (NUS) and the University of Oxford, announced on the 21st of July that they have elucidated the structure and function of the 'DM3' protein complex, which triggers plant autoimmune responses, using cryo-electron microscopy (Cryo-EM) technology.
This research is drawing attention because it identifies defects in protein structure as the cause of hybrid necrosis, which occurs due to an abnormal reaction of immune receptors during cross-breeding between plant hybrids.
This protein (DM3) is originally an enzyme involved in the plant's immune response, but problems arise when the structure of the DM3 protein is damaged in a specific protein combination called 'DANGEROUS MIX (DM)'.
Notably, one variant of DM3, the 'DM3Col-0' variant, forms a stable complex with six proteins and is recognized as normal, thus not triggering an immune response. In contrast, another 'DM3Hh-0' variant has improper binding between its six proteins, causing the plant to recognize it as an 'abnormal state' and trigger an immune alarm, leading to autoimmunity.
The research team visualized this structure using atomic-resolution cryo-electron microscopy (Cryo-EM) and revealed that the immune-inducing ability is not due to the enzymatic function of the DM3 protein, but rather to 'differences in protein binding affinity.'
<Figure 1. Mechanism of Plant Autoimmunity Triggered by the Collapse of the DM3 Protein Complex>
This demonstrates that plants can initiate an immune response by recognizing not only 'external pathogens' but also 'internal protein structures' when they undergo abnormal changes, treating them as if they were pathogens.
The study shows how sensitively the plant immune system changes and triggers autoimmune responses when genes are mixed and protein structures change during the cross-breeding of different plant varieties. It significantly advanced the understanding of genetic incompatibility that can occur during natural cross-breeding and cultivar improvement processes.
Dr. Gijeong Kim, the co-first author, stated, "Through international research collaboration, we presented a new perspective on understanding the plant immune system by leveraging the autoimmune phenomenon, completing a high-quality study that encompasses structural biochemistry, genetics, and cell biological experiments."
Professor Ji-Joon Song of the KAIST Department of Biological Sciences, who led the research, said, "The fact that the immune system can detect not only external pathogens but also structural abnormalities in its own proteins will set a new standard for plant biotechnology and crop breeding strategies. Cryo-electron microscopy-based structural analysis will be an important tool for understanding the essence of gene interactions."
This research, with Professor Ji-Joon Song and Professor Eunyoung Chae of the University of Oxford as co-corresponding authors, Dr. Gijeong Kim (currently a postdoctoral researcher at the University of Zurich) and Dr. Wei-Lin Wan of the National University of Singapore as co-first authors, and Ph.D candidate Nayun Kim, as the second author, was published on July 17th in Molecular Cell, a sister journal of the international academic journal Cell.
This research was supported by the KAIST Grand Challenge 30 project.
Article Title: Structural determinants of DANGEROUS MIX 3, an alpha/beta hydrolase that triggers NLR-mediated genetic incompatibility in plants DOI: https://doi.org/10.1016/j.molcel.2025.06.021
2025.07.21 View 540 -
KAIST Holds '2025 KAIST Science Frontier Camp' for Multicultural Youth
<2025 KAIST Science Frontier Camp Activities>
KAIST (President Kwang Hyung Lee) announced on the 18th of July that it hosted the '2025 KAIST Science Frontier Camp' for multicultural youth from the 15th for three days and two nights at the Creative Learning Building on its main campus in Daejeon.
This event was organized in accordance with the 'Multicultural Talent Nurturing Agreement' signed by KAIST and GS Caltex in 2024. It marks the first year of a mid-to-long-term project in which 100 million KRW in development funds will be contributed annually for four years. The Global Institute for Talented Education organized the camp, and approximately 30 middle school students from multicultural families affiliated with the 'Hanmaum Educational Volunteer Group' (Director, Honorary Professor Byung Kyu Choi), a mentoring and volunteer organization for multicultural students, participated.
The camp participants enjoyed developing their scientific thinking skills and problem-solving abilities, and broadening their understanding of STEM (Science, Technology, Engineering, and Mathematics) career paths through a variety of science activity programs, including: △'Black Box: Record the Egg's Last Moment!' △'Find the Best Strategy! Heuristic Algorithm Challenge' △'Future Society and AI, Finding Career Directions' △'Distance Dominates the World!' and △'Career Talk Concert.'
During the opening ceremony, Director Byung Kyu Choi delivered a congratulatory speech. Additionally, Yong Hyun Kim, Dean of Admissions at KAIST, gave a special lecture titled 'La La Land KAIST – A Story of Chasing the Dream of a Young Scientist,' sharing honest stories about careers and dreams as a scientist.
Gi Jung Yoo, a freshman from the Division of Undeclared Majors who participated in the camp as a student mentor, shared that he had a very meaningful time mentoring the participating students, who are future STEM hopefuls, sharing vivid experiences as well as insights on metric functions. He added his hope that more students would be given such opportunities.
< Students Actively Taking Part in the Camp Activities>
Si Jong Kwak, Director of the Global Institute for Talented Education, stated, "We hope this will be a practical way to help students foster their interest in science, learn the joy of discussion and communication, and design their future."
KAIST President Kwang Hyung Lee remarked, "This camp was a valuable opportunity for students from diverse cultural backgrounds to gain confidence through science and envision their future." He added, "KAIST will continue to dedicate efforts to nurturing multicultural talent and contribute to creating a sustainable society."
Since 2024, KAIST has introduced and selected multicultural students through its Equal Opportunity Admission track. Utilizing the development funds from GS Caltex, KAIST also established the 'GS Caltex Multicultural Excellence Scholarship Program.' Through this scholarship program, undergraduate students from multicultural families receive living expenses each semester, allowing them to focus more stably on their studies. As the number of applicants for the Equal Opportunity Admission track is increasing every year, more multicultural students are expected to benefit from scholarships in the future.
Additionally, in May, both organizations invited Ms. Si Si Wu Fong, a foreign employee at GS Caltex, to give a special lecture titled 'Working Life for Foreigners in Korea' to support foreign students' career exploration. Foreign students who attended the lecture reported positive feedback, stating that they gained practical career information and were motivated to pursue employment in STEM fields in Korea.
KAIST plans to continue strengthening its efforts to nurture multicultural talent, increase understanding of the upcoming multicultural society, and help spread social values.
<At the 2025 KAIST Science Frontier Camp>
2025.07.18 View 537 -
KAIST Successfully Implements 3D Brain-Mimicking Platform with 6x Higher Precision
<(From left) Dr. Dongjo Yoon, Professor Je-Kyun Park from the Department of Bio and Brain Engineering, (upper right) Professor Yoonkey Nam, Dr. Soo Jee Kim>
Existing three-dimensional (3D) neuronal culture technology has limitations in brain research due to the difficulty of precisely replicating the brain's complex multilayered structure and the lack of a platform that can simultaneously analyze both structure and function. A KAIST research team has successfully developed an integrated platform that can implement brain-like layered neuronal structures using 3D printing technology and precisely measure neuronal activity within them.
KAIST (President Kwang Hyung Lee) announced on the 16th of July that a joint research team led by Professors Je-Kyun Park and Yoonkey Nam from the Department of Bio and Brain Engineering has developed an integrated platform capable of fabricating high-resolution 3D multilayer neuronal networks using low-viscosity natural hydrogels with mechanical properties similar to brain tissue, and simultaneously analyzing their structural and functional connectivity.
Conventional bioprinting technology uses high-viscosity bioinks for structural stability, but this limits neuronal proliferation and neurite growth. Conversely, neural cell-friendly low-viscosity hydrogels are difficult to precisely pattern, leading to a fundamental trade-off between structural stability and biological function. The research team completed a sophisticated and stable brain-mimicking platform by combining three key technologies that enable the precise creation of brain structure with dilute gels, accurate alignment between layers, and simultaneous observation of neuronal activity.
The three core technologies are: ▲ 'Capillary Pinning Effect' technology, which enables the dilute gel (hydrogel) to adhere firmly to a stainless steel mesh (micromesh) to prevent it from flowing, thereby reproducing brain structures with six times greater precision (resolution of 500 μm or less) than conventional methods; ▲ the '3D Printing Aligner,' a cylindrical design that ensures the printed layers are precisely stacked without misalignment, guaranteeing the accurate assembly of multilayer structures and stable integration with microelectrode chips; and ▲ 'Dual-mode Analysis System' technology, which simultaneously measures electrical signals from below and observes cell activity with light (calcium imaging) from above, allowing for the simultaneous verification of the functional operation of interlayer connections through multiple methods.
< Figure 1. Platform integrating brain-structure-mimicking neural network model construction and functional measurement technology>
The research team successfully implemented a three-layered mini-brain structure using 3D printing with a fibrin hydrogel, which has elastic properties similar to those of the brain, and experimentally verified the process of actual neural cells transmitting and receiving signals within it.
Cortical neurons were placed in the upper and lower layers, while the middle layer was left empty but designed to allow neurons to penetrate and connect through it. Electrical signals were measured from the lower layer using a microsensor (electrode chip), and cell activity was observed from the upper layer using light (calcium imaging). The results showed that when electrical stimulation was applied, neural cells in both upper and lower layers responded simultaneously. When a synapse-blocking agent (synaptic blocker) was introduced, the response decreased, proving that the neural cells were genuinely connected and transmitting signals.
Professor Je-Kyun Park of KAIST explained, "This research is a joint development achievement of an integrated platform that can simultaneously reproduce the complex multilayered structure and function of brain tissue. Compared to existing technologies where signal measurement was impossible for more than 14 days, this platform maintains a stable microelectrode chip interface for over 27 days, allowing the real-time analysis of structure-function relationships. It can be utilized in various brain research fields such as neurological disease modeling, brain function research, neurotoxicity assessment, and neuroprotective drug screening in the future."
The research, in which Dr. Soo Jee Kim and Dr. Dongjo Yoon from KAIST's Department of Bio and Brain Engineering participated as co-first authors, was published online in the international journal 'Biosensors and Bioelectronics' on June 11, 2025.
※Paper: Hybrid biofabrication of multilayered 3D neuronal networks with structural and functional interlayer connectivity
※DOI: https://doi.org/10.1016/j.bios.2025.117688
2025.07.16 View 587 -
KAIST Develops Robots That React to Danger Like Humans
<(From left) Ph.D candidate See-On Park, Professor Jongwon Lee, and Professor Shinhyun Choi>
In the midst of the co-development of artificial intelligence and robotic advancements, developing technologies that enable robots to efficiently perceive and respond to their surroundings like humans has become a crucial task. In this context, Korean researchers are gaining attention for newly implementing an artificial sensory nervous system that mimics the sensory nervous system of living organisms without the need for separate complex software or circuitry. This breakthrough technology is expected to be applied in fields such as in ultra-small robots and robotic prosthetics, where intelligent and energy-efficient responses to external stimuli are essential.
KAIST (President Kwang Hyung Lee) announced on July15th that a joint research team led by Endowed Chair Professor Shinhyun Choi of the School of Electrical Engineering at KAIST and Professor Jongwon Lee of the Department of Semiconductor Convergence at Chungnam National University (President Jung Kyum Kim) developed a next-generation neuromorphic semiconductor-based artificial sensory nervous system. This system mimics the functions of a living organism's sensory nervous system, and enables a new type of robotic system that can efficiently responds to external stimuli.
In nature, animals — including humans — ignore safe or familiar stimuli and selectively react sensitively to important or dangerous ones. This selective response helps prevent unnecessary energy consumption while maintaining rapid awareness of critical signals. For instance, the sound of an air conditioner or the feel of clothing against the skin soon become familiar and are disregarded. However, if someone calls your name or a sharp object touches your skin, a rapid focus and response occur. These behaviors are regulated by the 'habituation' and 'sensitization' functions in the sensory nervous system. Attempts have been consistently made to apply these sensory nervous system functions of living organisms in order to create robots that efficiently respond to external environments like humans.
However, implementing complex neural characteristics such as habituation and sensitization in robots has faced difficulties in miniaturization and energy efficiency due to the need for separate software or complex circuitry. In particular, there have been attempts to utilize memristors, a neuromorphic semiconductor. A memristor is a next-generation electrical device, which has been widely utilized as an artificial synapse due to its ability to store analog value in the form of device resistance. However, existing memristors had limitations in mimicking the complex characteristics of the nervous system because they only allowed simple monotonic changes in conductivity.
To overcome these limitations, the research team developed a new memristor capable of reproducing complex neural response patterns such as habituation and sensitization within a single device. By introducing additional layer inside the memristor that alter conductivity in opposite directions, the device can more realistically emulate the dynamic synaptic behaviors of a real nervous system — for example, decreasing its response to repeated safe stimuli but quickly regaining sensitivity when a danger signal is detected.
<New memristor mimicking functions of sensory nervous system such as habituation/sensitization>
Using this new memristor, the research team built an artificial sensory nervous system capable of recognizing touch and pain, an applied it to a robotic hand to test its performance. When safe tactile stimuli were repeatedly applied, the robot hand, which initially reacted sensitively to unfamiliar tactile stimuli, gradually showed habituation characteristics by ignoring the stimuli. Later, when stimuli were applied along with an electric shock, it recognized this as a danger signal and showed sensitization characteristics by reacting sensitively again. Through this, it was experimentally proven that robots can efficiently respond to stimuli like humans without separate complex software or processors, verifying the possibility of developing energy-efficient neuro-inspired robots.
<Robot arm with memristor-based artificial sensory nervous system>
See-On Park, researcher at KAIST, stated, "By mimicking the human sensory nervous system with next-generation semiconductors, we have opened up the possibility of implementing a new concept of robots that are smarter and more energy-efficient in responding to external environments." He added, "This technology is expected to be utilized in various fusion fields of next-generation semiconductors and robotics, such as ultra-small robots, military robots, and medical robots like robotic prosthetics".
This research was published online on July 1st in the international journal 'Nature Communications,' with Ph.D candidate See-On Park as the first author.
Paper Title: Experimental demonstration of third-order memristor-based artificial sensory nervous system for neuro-inspired robotics
DOI: https://doi.org/10.1038/s41467-025-60818-x
This research was supported by the Korea National Research Foundation's Next-Generation Intelligent Semiconductor Technology Development Project, the Mid-Career Researcher Program, the PIM Artificial Intelligence Semiconductor Core Technology Development Project, the Excellent New Researcher Program, and the Nano Convergence Technology Division, National Nanofab Center's (NNFC) Nano-Medical Device Project.
2025.07.16 View 751 -
A KAIST Team Engineers a Microbial Platform for Efficient Lutein Production
<(From Left) Ph.D. Candidate Hyunmin Eun, Distinguished Professor Sang Yup Lee, , Dr. Cindy Pricilia Surya Prabowo>
The application of systems metabolic engineering strategies, along with the construction of an electron channeling system, has enabled the first gram-per-liter scale production of lutein from Corynebacterium glutamicum, providing a viable alternative to plant-derived lutein production.
A research group at KAIST has successfully engineered a microbial strain capable of producing lutein at industrially relevant levels. The team, led by Distinguished Professor Sang Yup Lee from the Department of Chemical and Biomolecular Engineering, developed a novel C. glutamicum strain using systems metabolic engineering strategies to overcome the limitations of previous microbial lutein production efforts. This research is expected to be beneficial for the efficient production of other industrially important natural products used in food, pharmaceuticals, and cosmetics.
Lutein is a xanthophyll carotenoid found in egg yolk, fruits, and vegetables, known for its role in protecting our eyes from oxidative stress and reducing the risk of macular degeneration and cataracts. Currently, commercial lutein is predominantly extracted from marigold flowers; however, this approach has several drawbacks, including long cultivation times, high labor costs, and inefficient extraction yields, making it economically unfeasible for large-scale production. These challenges have driven the demand for alternative production methods.
To address these issues, KAIST researchers, including Ph.D. Candidate Hyunmin Eun, Dr. Cindy Pricilia Surya Prabowo, and Distinguished Professor Sang Yup Lee, applied systems metabolic engineering strategies to engineer C. glutamicum, a GRAS (Generally Recognized As Safe) microorganism widely used in industrial fermentation. Unlike Escherichia coli, which was previously explored for microbial lutein production, C. glutamicum lacks endotoxins, making it a safer and more viable option for food and pharmaceutical applications.
The team’s work, entitled “Gram-per-litre scale production of lutein by engineered Corynebacterium,” was published in Nature Synthesis on 04 July , 2025.
This research details the high-level production of lutein using glucose as a renewable carbon source via systems metabolic engineering. The team focused on eliminating metabolic bottlenecks that previously limited microbial lutein synthesis. By employing enzyme scaffold-based electron channeling strategies, the researchers improved metabolic flux towards lutein biosynthesis while minimizing unwanted byproducts.
<Lutein production metabolic pathway engineering>
To enhance productivity, bottleneck enzymes within the metabolic pathway were identified and optimized. It was determined that electron-requiring cytochrome P450 enzymes played a major role in limiting lutein biosynthesis. To overcome this limitation, an electron channeling strategy was implemented, where engineered cytochrome P450 enzymes and their reductase partners were spatially organized on synthetic scaffolds, allowing more efficient electron transfer and significantly increasing lutein production.
The engineered C. glutamicum strain was further optimized in fed-batch fermentation, achieving a record-breaking 1.78 g/L of lutein production within 54 hours, with a content of 19.51 mg/gDCW and a productivity of 32.88 mg/L/h—the highest lutein production performance in any host reported to date. This milestone demonstrates the feasibility of replacing plant-based lutein extraction with microbial fermentation technology.
“We can anticipate that this microbial cell factory-based mass production of lutein will be able to replace the current plant extraction-based process,” said Ph.D. Candidate Hyunmin Eun. He emphasized that the integrated metabolic engineering strategies developed in this study could be broadly applied for the efficient production of other valuable natural products used in pharmaceuticals and nutraceuticals.
<Schematic diagram of microbial-based lutein production platform>
“As maintaining good health in an aging society becomes increasingly important, we expect that the technology and strategies developed here will play pivotal roles in producing other medically and nutritionally significant natural products,” added Distinguished Professor Sang Yup Lee.
This work is supported by the Development of Next-generation Biorefinery Platform Technologies for Leading Bio-based Chemicals Industry project 2022M3J5A1056072 and the Development of Platform Technologies of Microbial Cell Factories for the Next-Generation Biorefineries project 2022M3J5A1056117 from the National Research Foundation supported by the Korean Ministry of Science and ICT.
Source:
Hyunmin Eun (1st), Cindy Pricilia Surya Prabowo (co-1st), and Sang Yup Lee (Corresponding). “Gram-per-litre scale production of lutein by engineered Corynebacterium”. Nature Synthesis (Online published)
For further information:
Sang Yup Lee, Distinguished Professor of Chemical and Biomolecular Engineering, KAIST (leesy@kaist.ac.kr, Tel: +82-42-350-3930)
2025.07.14 View 1184 -
KAIST Develops Novel Candidiasis Treatment Overcoming Side Effects and Resistance
<(From left) Ph. D Candidate Ju Yeon Chung, Prof.Hyun Jung Chung, Ph.D candidate Seungju Yang, Ph.D candidate Ayoung Park, Dr. Yoon-Kyoung Hong from Asan Medical Center, Prof. Yong Pil Chong, Dr. Eunhee Jeon>
Candida, a type of fungus, which can spread throughout the body via the bloodstream, leading to organ damage and sepsis. Recently, the incidence of candidiasis has surged due to the increase in immunosuppressive therapies, medical implants, and transplantation. Korean researchers have successfully developed a next-generation treatment that, unlike existing antifungals, selectively acts only on Candida, achieving both high therapeutic efficacy and low side effects simultaneously.
KAIST (President Kwang Hyung Lee) announced on the 8th that a research team led by Professor Hyun-Jung Chung of the Department of Biological Sciences, in collaboration with Professor Yong Pil Jeong's team at Asan Medical Center, developed a gene-based nanotherapy (FTNx) that simultaneously inhibits two key enzymes in the Candida cell wall.
Current antifungal drugs for Candida have low target selectivity, which can affect human cells. Furthermore, their therapeutic efficacy is gradually decreasing due to the emergence of new resistant strains. Especially for immunocompromised patients, the infection progresses rapidly and has a poor prognosis, making the development of new treatments to overcome the limitations of existing therapies urgent.
The developed treatment can be administered systemically, and by combining gene suppression technology with nanomaterial technology, it effectively overcomes the structural limitations of existing compound-based drugs and successfully achieves selective treatment against only Candida.
The research team created a gold nanoparticle-based complex loaded with short DNA fragments called antisense oligonucleotides (ASO), which simultaneously target two crucial enzymes—β-1,3-glucan synthase (FKS1) and chitin synthase (CHS3)—important for forming the cell wall of the Candida fungus.
By applying a surface coating technology that binds to a specific glycolipid structure (a structure combining sugar and fat) on the Candida cell wall, a targeted delivery device was implemented. This successfully achieved a precise targeting effect, ensuring the complex is not delivered to human cells at all but acts selectively only on Candida.
<Figure 1: Overview of antifungal therapy design and experimental approach>
This complex, after entering Candida cells, cleaves the mRNA produced by the FKS1 and CHS3 genes, thereby inhibiting translation and simultaneously blocking the synthesis of cell wall components β-1,3-glucan and chitin. As a result, the
Candida cell wall loses its structural stability and collapses, suppressing bacterial survival and proliferation.
In fact, experiments using a systemic candidiasis model in mice confirmed the therapeutic effect: a significant reduction in
Candida count in the organs, normalization of immune responses, and a notable increase in survival rates were observed in the treated group.
Professor Hyun-Jung Chung, who led the research, stated, "This study presents a method to overcome the issues of human toxicity and drug resistance spread with existing treatments, marking an important turning point by demonstrating the applicability of gene therapy for systemic infections". She added, "We plan to continue research on optimizing administration methods and verifying toxicity for future clinical application."
This research involved Ju Yeon Chung and Yoon-Kyoung Hong as co-first authors , and was published in the international journal 'Nature Communications' on July 1st.
Paper Title: Effective treatment of systemic candidiasis by synergistic targeting of cell wall synthesis
DOI: 10.1038/s41467-025-60684-7
This research was supported by the Ministry of Health and Welfare and the National Research Foundation of Korea.
2025.07.08 View 725 -
KAIST Uses AI to Discover Optimal New Material for Removing Radioactive Iodine Contamination
<(From the Right) Professor Ho Jin Ryu, Department of Nuclear and Quantum Engineering, Dr. Sujeong Lee, a graduate of the KAIST Department of Materials Science and Engineering, and Dr. Juhwan Noh of KRICT’s Digital Chemistry Research Center>
Managing radioactive waste is one of the core challenges in the use of nuclear energy. In particular, radioactive iodine poses serious environmental and health risks due to its long half-life (15.7 million years in the case of I-129), high mobility, and toxicity to living organisms. A Korean research team has successfully used artificial intelligence to discover a new material that can remove iodine for nuclear environmental remediation. The team plans to push forward with commercialization through various industry-academia collaborations, from iodine-adsorbing powders to contaminated water treatment filters.
KAIST (President Kwang Hyung Lee) announced on the 2of July that Professor Ho Jin Ryu's research team from the Department of Nuclear and Quantum Engineering, in collaboration with Dr. Juhwan Noh of the Digital Chemistry Research Center at the Korea Research Institute of Chemical Technology (KRICT, President Young Kook Lee), which operates under the National Research Council of Science & Technology (NST, Chairman Youngsik Kim), developed a technique using AI to discover new materials that effectively remove radioactive iodine contaminants.
Recent studies show that radioactive iodine primarily exists in aqueous environments in the form of iodate (IO₃⁻). However, existing silver-based adsorbents have weak chemical adsorption strength for iodate, making them inefficient. Therefore, it is imperative to develop new adsorbent materials that can effectively remove iodate.
Professor Ho Jin Ryu’s team used a machine learning-based experimental strategy to identify optimal iodate adsorbents among compounds called Layered Double Hydroxides (LDHs), which contain various metal elements.
The multi-metal LDH developed in this study – Cu₃(CrFeAl), based on copper, chromium, iron, and aluminum—showed exceptional adsorption performance, removing over 90% of iodate. This achievement was made possible by efficiently exploring a vast compositional space using AI-driven active learning, which would be difficult to search through conventional trial-and-error experiments.
<Picture2. Concept of Developed AI-Based Technology for Exploring New Materials for Radioactive Contamination Removal>
The research team focused on the fact that LDHs, like high-entropy materials, can incorporate a wide range of metal compositions and possess structures favorable for anion adsorption. However, due to the overwhelming number of possible metal combinations in multi-metal LDHs, identifying the optimal composition through traditional experimental methods has been nearly impossible.
To overcome this, the team employed AI (machine learning). Starting with experimental data from 24 binary and 96 ternary LDH compositions, they expanded their search to include quaternary and quinary candidates. As a result, they were able to discover the optimal material for iodate removal by testing only 16% of the total candidate materials.
Professor Ho Jin Ryu stated, “This study shows the potential of using artificial intelligence to efficiently identify radioactive decontamination materials from a vast pool of new material candidates, which is expected to accelerate research for developing new materials for nuclear environmental cleanup.”
The research team has filed a domestic patent application for the developed powder technology and is currently proceeding with an international patent application. They plan to enhance the material’s performance under various conditions and pursue commercialization through industry-academia cooperation in the development of filters for treating contaminated water.
Dr. Sujeong Lee, a graduate of the KAIST Department of Materials Science and Engineering, and Dr. Juhwan Noh of KRICT’s Digital Chemistry Research Center, participated as the co-first authors of the study. The results were published online on May 26 in the internationally renowned environmental publication Journal of Hazardous Materials.
※ Paper title: Discovery of multi-metal-layered double hydroxides for decontamination of iodate by machine learning-assisted experiments ※ DOI: https://doi.org/10.1016/j.jhazmat.2025.138735
This research was supported by the Nuclear Energy Research Infrastructure Program and the Nano-Materials Technology Development Program funded by the Ministry of Science and ICT and the National Research Foundation of Korea.
2025.07.03 View 1376 -
KAIST Enhances Immunotherapy for Difficult-to-Treat Brain Tumors with Gut Microbiota
< Photo 1.(From left) Prof. Heung Kyu Lee, Department of Biological Sciences,
and Dr. Hyeon Cheol Kim>
Advanced treatments, known as immunotherapies that activate T cells—our body's immune cells—to eliminate cancer cells, have shown limited efficacy as standalone therapies for glioblastoma, the most lethal form of brain tumor. This is due to their minimal response to glioblastoma and high resistance to treatment.
Now, a KAIST research team has now demonstrated a new therapeutic strategy that can enhance the efficacy of immunotherapy for brain tumors by utilizing gut microbes and their metabolites. This also opens up possibilities for developing microbiome-based immunotherapy supplements in the future.
KAIST (President Kwang Hyung Lee) announced on July 1 that a research team led by Professor Heung Kyu Lee of the Department of Biological Sciences discovered and demonstrated a method to significantly improve the efficiency of glioblastoma immunotherapy by focusing on changes in the gut microbial ecosystem.
The research team noted that as glioblastoma progresses, the concentration of ‘tryptophan’, an important amino acid in the gut, sharply decreases, leading to changes in the gut microbial ecosystem. They discovered that by supplementing tryptophan to restore microbial diversity, specific beneficial strains activate CD8 T cells (a type of immune cell) and induce their infiltration into tumor tissues. Through a mouse model of glioblastoma, the research team confirmed that tryptophan supplementation enhanced the response of cancer-attacking T cells (especially CD8 T cells), leading to their increased migration to tumor sites such as lymph nodes and the brain.
In this process, they also revealed that ‘Duncaniella dubosii’, a beneficial commensal bacterium present in the gut, plays a crucial role. This bacterium helped T cells effectively redistribute within the body, and survival rates significantly improved when used in combination with immunotherapy (anti-PD-1).
Furthermore, it was demonstrated that even when this commensal bacterium was administered alone to germ-free mice (mice without any commensal microbes), the survival rate for glioblastoma increased. This is because the bacterium utilizes tryptophan to regulate the gut environment, and the metabolites produced in this process strengthen the ability of CD8 T cells to attack cancer cells.
Professor Heung Kyu Lee explained, "This research is a meaningful achievement, showing that even in intractable brain tumors where immune checkpoint inhibitors had no effect, a combined strategy utilizing gut microbes can significantly enhance treatment response."
Dr. Hyeon Cheol Kim of KAIST (currently a postdoctoral researcher at the Institute for Biological Sciences) participated as the first author. The research findings were published online in Cell Reports, an international journal in the life sciences, on June 26.
This research was conducted as part of the Basic Research Program and Bio & Medical Technology Development Program supported by the Ministry of Science and ICT and the National Research Foundation of Korea.
※Paper Title: Gut microbiota dysbiosis induced by brain tumor modulates the efficacy of immunotherapy
※DOI: https://doi.org/10.1016/j.celrep.2025.115825
2025.07.02 View 1455